Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106–e116
Colijn JM, Buitendijk GH, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP et al (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology 124(12):1753–1763
Shinojima A, Sawa M, Mori R, Sekiryu T, Oshima Y, Kato A et al (2020) Five-year follow-up of fundus autofluorescence and retinal sensitivity in the fellow eye in exudative age-related macular degeneration in Japan. PLoS ONE 15(3):e0229694
Article CAS PubMed PubMed Central Google Scholar
Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112(4):533–9
Pennington KL, DeAngelis MM (2016) Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 3:34
Thomas CJ, Mirza RG, Gill MK (2021) Age-related macular degeneration. Med Clin North Am 105(3):473–491
Csaky KG, Schachat AP, Kaiser PK, Small KW, Heier JS (2017) The use of genetic testing in the management of patients with age-related macular degeneration: American Society of Retina Specialists Genetics Task Force Special Report. J VitreoRetinal Dis 1(1):75–78
Amissah-Arthur KN, Panneerselvam S, Narendran N, Yang YC (2012) Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration. Eye 26(3):394–399
Article CAS PubMed Google Scholar
Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, Iijima H (2019) Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol 63(5):374–381
Article CAS PubMed Google Scholar
Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I et al (2018) Incidence of fellow eye involvement in patients with unilateral exudative age-related macular degeneration. JAMA Ophthalmol 136(8):905–911
Article PubMed PubMed Central Google Scholar
Gangnon RE, Lee KE, Klein BE, Iyengar SK, Sivakumaran TA, Klein R (2015) Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study. JAMA Ophthalmol 133(2):125–132
Article PubMed PubMed Central Google Scholar
Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS et al (2015) Detection of non-exudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina (Philadelphia, Pa) 35(11):2204
Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen C-L et al (2016) Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology 123(6):1309–1319
Yanagi Y, Mohla A, Lee W-K, Lee SY, Mathur R, Chan CM et al (2017) Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 58(9):3488–3495
Bek T, Klug SE (2018) Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch Clin Exp Ophthalmol 256(11):2061–2068
Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R et al (2008) Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol 146(1):96-101. e2
Bochicchio S, Xhepa A, Secondi R, Acquistapace A, Oldani M, Cigada MV et al (2019) The incidence of neovascularization in the fellow eye of patients with unilateral choroidal lesion: a survival analysis. Ophthalmol Retina 3(1):27–31
Burgess DB, Jefferys JL (1993) Extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199
Tufail A, Xing W, Johnston R, Akerele T, McKibbin M, Downey L et al (2014) The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections. Ophthalmology 121(5):1092–1101
Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M et al (2014) The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. Ophthalmology 121(10):1966–1975
Fasler K, Fu DJ, Moraes G, Wagner S, Gokhale E, Kortuem K et al (2020) Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration. Br J Ophthalmol 104(5):684–690
Yuzawa M, Hagita K, Egawa T, Minato H, Matsui M (1991) Macular lesions predisposing to senile disciform macular degeneration. Jpn J Ophthalmol 35(1):87–95
Burgess D, Hawkins B, Jefferys J (1993) Macular Photocoagulation Study Group: five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199
Sandberg MA, Weiner A, Miller S, Gaudio AR (1998) High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105(3):441–447
Article CAS PubMed Google Scholar
Uyama M, Takahashi K, Ida N, Miyashiro M, Ando A, Takahashi A et al (2000) The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 84(9):1018–1023
Article CAS PubMed PubMed Central Google Scholar
Bhisitkul RB, Desai SJ, Boyer DS, Sadda SR, Zhang K (2016) Fellow eye comparisons for 7-year outcomes in ranibizumab-treated AMD subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study). Ophthalmology 123(6):1269–1277
Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112(5):787–798
Laitinen A, Laatikainen L, Härkänen T, Koskinen S, Reunanen A, Aromaa A (2010) Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol 88(4):463–471
Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3):571–580
Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G et al (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:1–13
Snow KK, Cote J, Yang W, Davis NJ, Seddon JM (2002) Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 134(6):842–848
Article CAS PubMed Google Scholar
Smith W, Mitchell P, Wang J (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25(4):13–15
Hyman L, Neborsky R (2002) Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 13(3):171–175. https://doi.org/10.1097/00055735-200206000-00007
留言 (0)